# InnovAge Holding Corp. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/InnovAge Holding Corp.). ## Overview InnovAge Holding Corp. operates a PACE-based healthcare delivery platform for frail seniors, with care centered on all-inclusive, capitated services for participants who are often dually eligible for Medicare and Medicaid. The company is headquartered in Denver and runs one reportable segment, PACE, across centers in six U.S. states. ## Products & services • PACE program care delivery for frail seniors • All-inclusive capitated Medicare/Medicaid participant care • Primary, preventive, and specialty care coordination • In-center adult day health and interdisciplinary care teams • Pharmacy services and pharmacy cost-management support • Participant enrollment and care management services - **PACE care delivery** (98%) — Integrated medical, social, and supportive care delivered through PACE centers and home/community services. - **Capitation revenue** (97%) — Monthly per-participant payments from Medicare and Medicaid under state PACE contracts. - **Other service revenue** (1%) — Ancillary revenue mainly from state food grants and rent-related income. - **Pharmacy operations** (1%) — Acquired pharmacy assets and related management services supporting participant medication needs. - PACE program care delivery for frail seniors - All-inclusive capitated Medicare/Medicaid participant care - Primary, preventive, and specialty care coordination - In-center adult day health and interdisciplinary care teams - Pharmacy services and pharmacy cost-management support - Participant enrollment and care management services ## Customers InnovAge serves older adults who are medically complex, often dual-eligible for Medicare and Medicaid, and eligible for nursing-home-level care but able to remain in the community with support. Its economic buyers are primarily government payors through capitated state PACE contracts, while participants and their families are the end users of the care model. The company also works with hospitals, health systems, and other care providers in joint ventures and referral relationships to expand access in target markets. - **Dual-eligible seniors** (primary) — Older adults covered by both Medicare and Medicaid who need coordinated, all-inclusive care. - **PACE-eligible frail seniors** (primary) — Participants meeting nursing-home-level-of-care criteria who use PACE to stay in the community. - **Government payors** (primary) — State Medicaid agencies and Medicare arrangements that fund the capitated model. - **Health system partners** (secondary) — Hospitals and local providers that support market entry, referrals, and joint ventures. - Dual-eligible seniors needing coordinated long-term care - Participants eligible for nursing-home-level support but living in the community - Medicare and Medicaid state payors funding capitated PACE care - Hospitals and health systems in joint ventures and referral networks - Families and caregivers seeking integrated senior care ## Geography InnovAge is a U.S.-only operator with centers in California, Colorado, Florida, New Mexico, Pennsylvania, and Virginia. Its footprint is concentrated in state-by-state PACE markets, where local contracting, regulatory compliance, and provider relationships determine growth. The company is also expanding through de novo centers and partnerships in selected target markets, including Florida. - **United States** (100%) — All disclosed operations and revenue are U.S.-based. - U.S. operations only, with no disclosed international revenue - 20 PACE centers across six states - California and Pennsylvania are important contract markets - Florida is a growth market with new de novo centers - Local state contracting and regulation shape expansion ## Strategy InnovAge is focused on filling existing center capacity, opening de novo centers, and using tuck-in acquisitions and partnerships to expand its PACE platform. Management also emphasizes tighter regulatory compliance and stronger relationships with Medicare and Medicaid payors, since the model depends on stable capitated reimbursement and successful state contracting. - **Grow census at existing centers** (short-term) — Higher participant density improves operating leverage in a capitated care model. - **Build de novo centers** (medium-term) — New centers expand the platform into attractive markets and support long-term unit economics. - **Acquire and partner in target geographies** (medium-term) — Tuck-ins and joint ventures accelerate market entry and participant growth. - **Maintain regulatory compliance** (short-term) — PACE operations depend on state and federal compliance to preserve contracts and avoid remediation costs. - Increase participant enrollment and utilization at existing centers - Open de novo centers in target markets with attractive PACE economics - Pursue tuck-in acquisitions and strategic partnerships - Strengthen compliance to reduce audit and regulatory risk - Improve pharmacy cost-management and care delivery integration ## Risks InnovAge’s results depend on participant growth, state payor relationships, and strict compliance with PACE regulations, so execution failures can quickly affect revenue and margins. The company also faces healthcare-industry competition, cybersecurity and PHI/PII exposure, and added operational complexity from its new pharmacy business and debt maturities. - **Growth strategy may not prove viable** [high] — Expansion depends on new geographies, participant recruitment, and successful center execution. - **Regulatory and contractual compliance failures** [high] — PACE is heavily regulated and state contracts must be maintained in good standing. - **Dependence on government payors** [high] — The model relies on Medicare and Medicaid capitation rates and state contracting. - **Cybersecurity and privacy breaches** [medium] — The company and vendors handle sensitive PHI/PII and face HIPAA-related obligations. - **Pharmacy business execution risk** [medium] — InnovAge has limited prior experience operating pharmacy services and may not realize expected synergies. - **Refinancing and liquidity risk** [medium] — Debt maturities can pressure cash flow and require refinancing on acceptable terms. - Participant growth may stall if enrollment or retention weakens - State Medicaid/Medicare contracting is essential to the business model - Regulatory audits or remediation can raise costs and disrupt operations - Cybersecurity and PHI/PII exposure create legal and reputational risk - New pharmacy operations add execution and compliance complexity - Debt maturity and leverage increase refinancing risk ## Accounting The most important accounting judgments are revenue recognition under capitated PACE contracts, estimates tied to participant and provider costs, and the treatment of acquired businesses and pharmacy assets. Because revenue is largely monthly capitation and costs include significant third-party medical spend, small changes in participant census, utilization, or contract assumptions can move reported results materially. - **Capitation revenue recognition** — Affects timing and stability of reported revenue - **Participant and provider cost estimates** — Affects margins and quarterly earnings volatility - **Acquisition accounting for pharmacy assets** — Can affect amortization, goodwill, and future impairment risk - **Lease and center expansion accounting** — Affects right-of-use assets, depreciation, and occupancy costs - Capitation revenue recognition depends on participant eligibility and monthly rates - State contract timing can affect quarterly revenue comparability - External provider costs are the largest expense and require estimation - Acquired pharmacy assets may create valuation and integration accounting issues - Debt and lease balances affect interest expense and balance sheet leverage --- *Last updated: 2026-04-28T20:17:30.125159+00:00*